DRAFT : A 3 D printed microfluidic device with integrated biosensors for online subcutaneous human microdialysis
Sally A. N. Gowers,Vincenzo F. Curto,Carlo A. Seneci,Chu Wang,Salzitsa Anastasova,Pankaj,Vadgama,Guang-Zhong Yang,Martyn G. Boutelle
2016-01-01
Abstract:This work presents the design, fabrication and characterization of a robust 3D printed microfluidic analysis system that integrates with FDA-approved clinical microdialysis probes for continuous monitoring of human tissue metabolite levels. The microfluidic device incorporates removable needle type integrated biosensors for glucose and lactate housed in novel 3D printed electrode holders. A soft compressible 3D printed plastic at the base of the holder ensures a good seal with the microfluidic chip. We have shown how optimization of the channel size can significantly improve the response time of the sensor. As a proof-of-concept study, our microfluidic device was coupled to lab-built wireless potentiostats and used to monitor in real-time subcutaneous glucose and lactate levels in cyclists undergoing a training regime. In recent years there has been considerable interest in the development of wearable sensors to monitor a wide range of parameters, particularly with advances in body sensor networks (BSN), providing the wearer with realtime information about their health and fitness. Developments in wearable sensors have mainly focused on the measurement of vital signs such as heart rate and electrocardiographic change, however, the ability to use chemo/bio-sensors to monitor additional physiological parameters can provide important information in addition to these physical parameters. Among others, an area of particular interest in the use of wearable sensor technologies is sports. Access to real-time information can allow athletes to tailor their training to their individual characteristics, enabling them to assess their training effectiveness, to make adjustments and to track improvements in their performance. Extensive research efforts have focused on the development of miniaturized on-body chemo/bio-sensors for the measurement of physiological analytes in different bodily fluids, such as interstitial fluid, 5,6 sweat, tears and saliva. Glucose and lactate are particularly attractive biomarkers to monitor, for a wide range of applications, as they provide information about tissue oxygenation levels. Lactate, in particular, has received much interest for sports monitoring. During intense exercise, tissue oxygen levels are insufficient for aerobic metabolism to meet the energy demands of the body. Instead, anaerobic metabolism occurs, to meet these increased energy demands, leading to elevated lactate levels. Lactate can therefore be used as a measure of how hard the body is working, allowing athletes to modulate their effort accordingly, in order to train the body to increase its efficiency in clearing excess lactate or to avoid causing damage by over-training. Commercially available lactate and glucose meters, which are also used for sports applications, measure levels in the blood. Although blood measurements provide important information about metabolite levels in the body, the use of finger-prick test strips has several limitations. For instance, in order to improve temporal resolution, blood samples have to be taken regularly, resulting in constant interruptions during the activity period. However, the main limitation to discrete sampling is the lack of temporal resolution, with the result that it is not possible to observe dynamic changes in metabolite levels. In contrast, online microdialysis allows continuous monitoring of tissue metabolites, which, when coupled with an online analysis system, provides good temporal resolution, suitable for resolving dynamic changes. The microdialysis probe consists of a semi-permeable membrane, which is perfused with a physiological solution. Formation of a concentration gradient across the membrane allows exchange of molecules between the probe and the tissue, creating a dialysate stream that can be analyzed for compounds of interest. Microdialysis has been used in a wide range of applications and is an attractive technology for human in vivo monitoring, as commercial FDA-approved probes are available. Microdialysis combined with online analysis systems has been used extensively to detect tissue health and ischemic events. In particular, the lactate/glucose ratio has been shown to be an especially sensitive marker of tissue health, providing a clear indication as to whether tissue energy demands are being met. The combination of microfluidic devices with microdialysis has proven popular, due to their ability to reliably manipulate the small sample volumes produced during the continuous sampling of the dialysate. Conventionally, microfluidic devices have been fabricated using rapid prototyping methods, such as soft lithography. PDMS-based microfluidic devices, in particular, are the most common due to their ease of fabrication. PDMS chips have been used extensively for proof-of–concept analysis devices for mass spectrometry, as well as for optical and electrochemical detection. In all cases the analyzer is a large device placed on a bench near the experimental subject. In our current PDMS-needle biosensor system this requires >1 m of connection tubing between the probe and the PDMS chip, leading to a 30 min delay before analysis at 1μl/min flow rate, as well as a broadened temporal response due to Taylor dispersion. Furthermore, our current method forÍ manually positioning the needle electrode biosensors inside the PDMS chamber is impractical for a wearable device as movement caused by exercise leads to repositioning of the biosensor inside the microfluidic channel leading to noise and decreased sensitivity. Fast responding wearable devices need to be small, robust and placed close to the microdialysis probe outlet. For reliability, they require a robust low-volume connection to the probe and should ideally incorporate biosensors as easily replaceable modules, given the possibility of biosensor failure during high-value monitoring of athletes. Recently, there has been great interest in the use of 3D printing for the fabrication of microfluidic devices. This methodology is particularly attractive as it enables one-step fabrication of a microfluidic platform. It also enables dimensional control of the device, so that it can be integrated with commercially available components. The versatility of this fabrication method allows for a flexible, modular-approach to the device design, enabling fabrication of a multicomponent device, with each part designed to meet exact requirements. It also allows for design modifications to be made quickly and easily so that device features can be adjusted iteratively, and their influence on the device performance can be evaluated. Erkal et al. recently reported on the fabrication of 3D printed microfluidic devices with integrated electrodes for electrochemical detection. These devices were fabricated using commercial flangeless fitting nuts to house the electrodes, which integrated with microfabricated receiving ports. Here, we show for the first time, the development of a 3D printed microfluidic device that integrates with FDA-approved clinical microdialysis probes and incorporates needle type biosensors, and which can be used for continuous monitoring of human tissue metabolite levels. As a proof-of-concept, the device is employed for on-line monitoring of lactate and glucose tissue levels during cycling trials, providing a robust and reliable platform with potential use for wearable sensing technologies. EXPERIMENTAL SECTION